PHATHOM PHARMACEUTICAL

Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates

07 ноя 2024 07:00:01 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

04 ноя 2024 07:00:14 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024

28 окт 2024 07:00:49 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting

27 окт 2024 11:00:40 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

29 авг 2024 07:00:43 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants

19 авг 2024 07:00:19 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

08 авг 2024 07:00:08 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Commercially Insured Patients

30 июл 2024 07:00:01 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Report Second Quarter 2024 Financial Results and Provide Business Update on Thursday, August 8, 2024

29 июл 2024 06:59:41 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults

18 июл 2024 07:00:50 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

28 май 2024 07:00:00 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting

15 май 2024 07:00:00 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

09 май 2024 07:00:00 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024

29 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference

03 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”

26 мар 2024 07:00:05 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

07 мар 2024 07:00:50 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024

29 фев 2024 07:00:49 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients

13 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

31 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire